Jun 1, 2026 05:42AM
Jun 1, 2026 02:53AM
Jun 1, 2026 01:06AM
May 29, 2026 01:15PM
May 29, 2026 10:49AM
May 29, 2026 08:01AM
May 29, 2026 07:33AM Replimune To Resubmit Melanoma Treatment For Fda Approval - WSJ
May 12, 2026 12:50PM
May 8, 2026 01:32PM
Apr 14, 2026 10:44AM
Apr 13, 2026 10:15AM
Apr 13, 2026 03:41AM
Apr 13, 2026 03:41AM
Apr 13, 2026 01:54AM JPMorgan Downgrades Replimune Group (REPL) to Underweight
Apr 10, 2026 05:04PM
Apr 10, 2026 04:16PM
Apr 10, 2026 03:38PM
Apr 10, 2026 01:20PM
Apr 10, 2026 11:19AM
Apr 10, 2026 10:57AM
Apr 5, 2026 10:29AM Increasing unusual option volume: VFS CORN CODI BIZD CWAN REPL
Feb 4, 2026 06:54AM
Nov 12, 2025 07:43AM
Nov 7, 2025 04:45PM
Nov 3, 2025 12:04AM
Oct 27, 2025 06:44AM
Oct 20, 2025 02:52PM
Oct 20, 2025 02:27PM Replimune (REPL) call put ratio 1.2 calls to 1 put as share price up 105%
Oct 20, 2025 10:20AM
Oct 20, 2025 10:02AM
Oct 20, 2025 08:59AM
Oct 20, 2025 07:02AM
Sep 19, 2025 06:51AM
Sep 19, 2025 02:13AM
Sep 18, 2025 09:15AM Replimune meets with FDA on melanoma treatment application
Sep 9, 2025 06:50AM
Sep 2, 2025 08:02AM
Aug 11, 2025 05:30AM
Jul 31, 2025 02:12PM
Jul 31, 2025 05:01AM
Jul 30, 2025 01:43PM
Jul 30, 2025 10:03AM Increasing unusual option volume: REPL CP PGEN CRDF LC INDA NEO TTI JBS HOG TER
Jul 29, 2025 03:19PM
Jul 23, 2025 06:06AM
Jul 23, 2025 06:00AM
Jul 23, 2025 12:29AM
Jul 22, 2025 04:31PM
Jul 22, 2025 01:19PM
Jul 22, 2025 12:31PM Leerink Partners Reiterates Outperform Rating on Replimune Group (REPL), PT $21, 'Estimates Under Review'
Jul 22, 2025 11:18AM

413,572 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All